SARS-CoV-2 associated acute, motor and sensory, axonal neuropathy requires comprehensive diagnostic work-up

References

1. 1.↵
   1. AlTahan AM,
   2. AlAnazi MH,
   3. AlTahan FA,
   4. AlAbandi FA.

   Post COVID-19 Guillain-Barre syndrome presents as sensory dominant neuropathy with reversible conduction failure. Neurosciences (Riyadh) 2023; 28(1): 57–61.

   OpenUrlAbstract/FREE Full Text
2. 2.↵
   1. Kesav P,
   2. John S,
   3. Dogar MA,
   4. Al-Sharif K,
   5. Hussain Z.

   Multiple Cranial Nerve Enhancement in Guillain-Barre Syndrome With Clinicoradiological Dissociation. J Clin Neuromuscul Dis 2022; 23: 133–135.

   OpenUrl
3. 3.↵
   1. Llorente Ayuso L,
   2. Torres Rubio P

   , Beijinho do Rosário RF, Giganto Arroyo ML, Sierra-Hidalgo F. Bickerstaff encephalitis after COVID-19. J Neurol 2021; 268: 2035–2037.

   OpenUrl
4. 4.↵
   1. Gigli GL,
   2. Vogrig A,
   3. Nilo A,
   4. Fabris M,
   5. Biasotto A,
   6. Curcio F, et al.

   HLA and immunological features of SARS-CoV-2-induced Guillain-Barré syndrome. Neurol Sci 2020; 41: 3391–3394.

   OpenUrl
5. 5.↵
   1. Leonhard SE,
   2. Mandarakas MR,
   3. Gondim FA,
   4. Bateman K,
   5. Ferreira ML,
   6. Cornblath DR, et al.

   Diagnosis and management of Guillain–Barré syndrome in ten steps. Nat Rev Neurol 2019; 15: 671–683.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Odaka M,
   2. Yuki N,
   3. Yamada M, et al.

   Bickerstaff’s brainstem encephalitis: clinical features of 62 cases and a subgroup associated with Guillain-Barré syndrome. Brain 2003; 126: 2279–2290.

   OpenUrlCrossRefPubMedWeb of Science
7. 7.↵
   1. Shahrizaila N,
   2. Yuki N.

   Bickerstaff brainstem encephalitis and Fisher syndrome: anti-GQ1b antibody syndrome. J Neurol Neurosurg Psychiatry 2013; 84: 576–583.

   OpenUrlAbstract/FREE Full Text